V
Valeria Giudice
Researcher at University of Bologna
Publications - 25
Citations - 1165
Valeria Giudice is an academic researcher from University of Bologna. The author has contributed to research in topics: Stem cell & Transplantation. The author has an hindex of 12, co-authored 23 publications receiving 1043 citations.
Papers
More filters
Journal ArticleDOI
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
Antonio Curti,Loredana Ruggeri,Alessandra D'Addio,Andrea Bontadini,Elisa Dan,Maria Rosa Motta,Sara Trabanelli,Valeria Giudice,Elena Urbani,Giovanni Martinelli,Stefania Paolini,F. Fruet,Alessandro Isidori,Sarah Parisi,Giuseppe Bandini,Michele Baccarani,Andrea Velardi,Roberto M. Lemoli +17 more
TL;DR: Filtration of purified NK cells is feasible in elderly patients with high-risk acute myeloid leukemia, and donor NK cells were shown in vivo by the detection of donor-derived NK clones that killed recipient's targets.
Journal ArticleDOI
Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells.
Roberto M. Lemoli,Alessandra Fortuna,Maria Rosa Motta,Simonetta Rizzi,Valeria Giudice,Anna Nannetti,Giovanni Martinelli,Michele Cavo,Marilina Amabile,Serena Mangianti,Miriam Fogli,Roberto Conte,Sante Tura +12 more
TL;DR: The data show the concomitant mobilization of tumor cells and hematopoietic progenitors in the PB of multiple myeloma patients, as well as other clinically significant parameters, did not significantly differ from those of patients receiving unmanipulated PBSCs after the same pretransplant conditioning regimen.
Journal ArticleDOI
Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients.
Antonio Curti,Loredana Ruggeri,Sarah Parisi,Andrea Bontadini,Elisa Dan,Maria Rosa Motta,Simonetta Rizzi,Sara Trabanelli,Darina Očadlíková,Mariangela Lecciso,Valeria Giudice,F. Fruet,Elena Urbani,Cristina Papayannidis,Giovanni Martinelli,Giuseppe Bandini,Francesca Bonifazi,Russel Edward Lewis,Michele Cavo,Andrea Velardi,Roberto M. Lemoli +20 more
TL;DR: Infusion of purified NK cells is feasible in elderly AML patients as post-CR consolidation strategy and the clinical efficacy of adoptively transferred haploidentical NK cells may be improved by infusing high numbers of alloreactive NK cells.
Journal ArticleDOI
The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF
Alessandra D'Addio,Antonio Curti,Nina Worel,Kenneth W. Douglas,Maria Rosa Motta,Simonetta Rizzi,Elisa Dan,Simona Taioli,Valeria Giudice,Hermine Agis,G Kopetzky,R Soutar,Beatrice Casadei,Michele Baccarani,Roberto M. Lemoli +14 more
TL;DR: The results suggest that the pre-emptive addition of plerixafor to G-CSF after chemotherapy is safe and may allow the rescue of lymphoma and MM patients, who need autologous transplantation but are failing PBSC mobilization.
Journal ArticleDOI
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients
Alessandro Isidori,Monica Tani,Francesca Bonifazi,Pier Luigi Zinzani,Antonio Curti,Maria Rosa Motta,Simonetta Rizzi,Valeria Giudice,Oriana Farese,Manuela Rovito,Lapo Alinari,Roberto Conte,Michele Baccarani,Roberto M. Lemoli +13 more
TL;DR: The results show that pegfilgrastim as an adjunct to chemotherapy is a predictable and highly effective mobilization regimen in pretreated lymphoma patients.